• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头孢他啶皮下给药作为老年患者补救治疗的疗效和安全性:一例报告。

Efficacy and safety of subcutaneous administration of ceftazidime as a salvage therapy in geriatrics: a case report.

机构信息

Service de Pharmacie, Hôpitaux Universitaires Paris Ile-de-France Ouest, Site Sainte-Périne, AP-HP, 11 rue Chardon Lagache, Paris, 75016, France.

Service de Médecine Gériatrique, Hôpitaux Universitaires Paris Ile-de-France Ouest, Site Sainte-Périne, AP-HP, 11 rue Chardon Lagache, Paris, 75016, France.

出版信息

Fundam Clin Pharmacol. 2020 Aug;34(4):521-524. doi: 10.1111/fcp.12520. Epub 2019 Nov 25.

DOI:10.1111/fcp.12520
PMID:31709583
Abstract

Ceftazidime is a third-generation cephalosporin used for the treatment of Gram-negative bacteria only approved for parenteral use by intravenous and intramuscular route. In some clinical situations, off-label subcutaneous injection could be a salvage route for the administration of antibiotics, especially in geriatrics, despite the paucity of evidence about efficacy and safety. We report a case of a successful and well-tolerated subcutaneous ceftazidime therapy in a 90-year-old woman for the treatment of an acute urinary tract infection caused by Pseudomonas aeruginosa with therapeutic drug monitoring data.

摘要

头孢他啶是一种第三代头孢菌素,仅用于治疗革兰氏阴性菌,仅批准通过静脉和肌肉途径进行胃肠外给药。在某些临床情况下,超说明书的皮下注射可能是抗生素给药的一种挽救途径,特别是在老年患者中,尽管关于疗效和安全性的证据很少。我们报告了一例成功且耐受良好的 90 岁女性患者使用头孢他啶皮下治疗由铜绿假单胞菌引起的急性尿路感染的案例,该患者进行了治疗药物监测。

相似文献

1
Efficacy and safety of subcutaneous administration of ceftazidime as a salvage therapy in geriatrics: a case report.头孢他啶皮下给药作为老年患者补救治疗的疗效和安全性:一例报告。
Fundam Clin Pharmacol. 2020 Aug;34(4):521-524. doi: 10.1111/fcp.12520. Epub 2019 Nov 25.
2
Ceftazidime-avibactam or best available therapy in patients with ceftazidime-resistant Enterobacteriaceae and Pseudomonas aeruginosa complicated urinary tract infections or complicated intra-abdominal infections (REPRISE): a randomised, pathogen-directed, phase 3 study.头孢他啶-阿维巴坦或最佳现有治疗在头孢他啶耐药肠杆菌科和铜绿假单胞菌引起的复杂性尿路感染或复杂性腹腔内感染患者中的应用(REPRISE):一项随机、针对病原体的 3 期研究。
Lancet Infect Dis. 2016 Jun;16(6):661-673. doi: 10.1016/S1473-3099(16)30004-4. Epub 2016 Apr 20.
3
Treatment of complicated urinary tract infection caused by Pseudomonas aeruginosa--a comparison of the efficacy of ceftazidime with that of netilmicin.铜绿假单胞菌所致复杂性尿路感染的治疗——头孢他啶与奈替米星疗效比较
J Antimicrob Chemother. 1981 Sep;8 Suppl B:323-4. doi: 10.1093/jac/8.suppl_b.323.
4
Safety and Efficacy of Ceftazidime-Avibactam in the Treatment of Children ≥3 Months to <18 Years With Complicated Urinary Tract Infection: Results from a Phase 2 Randomized, Controlled Trial.头孢他啶-阿维巴坦治疗 3 个月至<18 岁复杂性尿路感染儿童的安全性和疗效:一项 2 期随机对照试验的结果。
Pediatr Infect Dis J. 2019 Sep;38(9):920-928. doi: 10.1097/INF.0000000000002395.
5
A successful antibiotic treatment by a new administration route: a case report of a subcutaneous administration of ceftazidime and tobramycin.一种新给药途径的成功抗生素治疗:头孢他啶和妥布霉素皮下给药的病例报告。
Fundam Clin Pharmacol. 2019 Dec;33(6):703-706. doi: 10.1111/fcp.12477. Epub 2019 May 24.
6
Use of ceftazidime in severe Gram-negative infections--a preliminary study.头孢他啶在严重革兰氏阴性菌感染中的应用——一项初步研究。
J Antimicrob Chemother. 1981 Sep;8 Suppl B:317-21. doi: 10.1093/jac/8.suppl_b.317.
7
[Pharmacodynamic optimization of ceftazidime against Pseudomonas aeruginosa: continuous infusion or intermittent administration?].[头孢他啶对铜绿假单胞菌的药效学优化:持续输注还是间歇给药?]
Rev Esp Quimioter. 2005 Mar;18(1):21-5.
8
Nebulized ceftazidime and amikacin in ventilator-associated pneumonia caused by Pseudomonas aeruginosa.雾化头孢他啶和阿米卡星治疗铜绿假单胞菌引起的呼吸机相关性肺炎。
Am J Respir Crit Care Med. 2011 Jul 1;184(1):106-15. doi: 10.1164/rccm.201011-1894OC. Epub 2011 Apr 7.
9
Evaluation of the usefulness of a novel injectable cephalosporin, E1040, and ceftazidime for management of complicated urinary tract infections caused by Pseudomonas aeruginosa and Proteus mirabilis by using the rat urolithiasis model.通过大鼠尿路结石模型评估新型注射用头孢菌素E1040和头孢他啶对铜绿假单胞菌和奇异变形杆菌所致复杂性尿路感染的治疗效果。
Antimicrob Agents Chemother. 1992 Jul;36(7):1580-3. doi: 10.1128/AAC.36.7.1580.
10
[Investigation on optimal regimen of ceftazidime against infection caused by Pseudomonas aeruginosa using Monte Carlo simulation].[基于蒙特卡洛模拟法探讨头孢他啶抗铜绿假单胞菌感染的优化方案]
Jpn J Antibiot. 2007 Dec;60(6):387-93.

引用本文的文献

1
Ceftazidime/Tobramycin Co-Loaded Chitosan-Coated Zein Nanoparticles against Antibiotic-Resistant and Biofilm-Producing and .头孢他啶/妥布霉素共载壳聚糖包被玉米醇溶蛋白纳米粒对抗抗生素耐药及生物膜产生菌和……(原文最后似乎不完整)
Pharmaceuticals (Basel). 2024 Feb 29;17(3):320. doi: 10.3390/ph17030320.
2
Olive oil nanoemulsion containing curcumin: antimicrobial agent against multidrug-resistant bacteria.含姜黄素的橄榄油纳米乳:抗多种耐药菌的抗菌剂。
Appl Microbiol Biotechnol. 2024 Feb 27;108(1):241. doi: 10.1007/s00253-024-13057-x.
3
The Subcutaneous Administration of Beta-Lactams: A Case Report and Literary Review-To Do Small Things in a Great Way.
β-内酰胺类药物的皮下给药:一例病例报告及文献综述——以伟大的方式做小事。
Infect Dis Rep. 2024 Jan 29;16(1):93-104. doi: 10.3390/idr16010007.
4
Pharmacokinetic/Pharmacodynamic Dosage Individualization of Suppressive Beta-Lactam Therapy Administered by Subcutaneous Route in Patients With Prosthetic Joint Infection.人工关节感染患者皮下注射β-内酰胺类抑制性治疗的药代动力学/药效学剂量个体化
Front Med (Lausanne). 2021 Mar 31;8:583086. doi: 10.3389/fmed.2021.583086. eCollection 2021.
5
Outpatient Subcutaneous Antimicrobial Therapy (OSCAT) as a Measure to Improve the Quality and Efficiency of Healthcare Delivery for Patients With Serious Bacterial Infections.门诊皮下抗菌治疗(OSCAT)作为提高严重细菌感染患者医疗服务质量和效率的一项措施
Front Med (Lausanne). 2020 Dec 23;7:585658. doi: 10.3389/fmed.2020.585658. eCollection 2020.